FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41059911000001101: Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Sep 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2260021000001117 Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2260041000001110 Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Is a Ripretinib 50mg tablets 90 tablet true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has AMP Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has specific active ingredient Ripretinib true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Qinlock 50mg tablets (Deciphera Pharmaceuticals (Netherlands) B.V.) 90 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start